Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,914 public trials 2,130 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

NCT05968326

Conditions
Adenocarcinoma, Adenocarcinoma, Pancreatic Ductal, Carcinoma, +3 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Cancer Center Newport Beach, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • University of California Los Angeles Santa Monica, California, United States
View all 87 locations
View Trial Details
Active, not recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

NCT03212274

Conditions
Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
Locations
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 51 locations
View Trial Details
Active, not recruiting

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

NCT00365157

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +9 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 26 locations
View Trial Details
Active, not recruiting

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

NCT05226871

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
View all 23 locations
View Trial Details
Active, not recruiting

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

NCT04534205

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations
  • UCLA Cancer Care Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • The George Washington Cancer Center Washington D.C., District of Columbia, United States
View all 145 locations
View Trial Details

Related conditions